B+
Bull case
25%
Probability
Target price
$32.00
Analysis reference price unavailable
Analysis 2026-09-17 · RankAlpha Sentiment Codex
KMTS
Kestra MedicalFNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
The quarter showed strong operating momentum: revenue grew 60%, gross margin expanded to 56.5% from 45.7%, and FY2027 revenue guidance increased to $141 million. Management cited share gains, market expansion, new territories, improved network mix and revenue-cycle execution.
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -1.3.
What can break
Commercial expansion and accelerated R&D spending could delay operating leverage and increase future financing risk.
Momentum
79
Value
36
Sentiment
39
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $27.00 · Bull $32.00 · Bear $17.00Analysis 2026-09-17; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-27 • Vendor: Data Vendor v1
Scores
As of 2026-10-27 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-17 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-27
Investment thesis
As of 2026-10-27
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-27. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $30.75
Why
Momentum79 · Δ7d -10.8
Value36 · Δ7d +0.0
Sentiment39 · Δ7d -1.3
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta -1.3.
Contradictions & invalidation
- • Commercial expansion and accelerated R&D spending could delay operating leverage and increase future financing risk.
- • Execution against the raised $141 million FY2027 revenue target depends on continued WCD market expansion, share gains, territory productivity, network mix and revenue-cycle improvements.
- • Growth remains expensive: operating expenses were $55.2 million, GAAP net loss widened to $44.1 million, and adjusted EBITDA loss deteriorated to $24.0 million.
Catalyst clock
2026-09-14
Revenue beat and guidance raise offset by earnings miss
Lead driver: Sentiment · See AI snapshot
Momentum
79
8% active weight
Current posture
7d trendSoftening
Δ7d
-10.8
Δ21d
-7.2
Value
36
47% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.0
Sentiment
39
45% active weight
Current posture
7d trendSoftening
Δ7d
-1.3
Δ21d
-11.0
Why this grade
Composite grade F. Momentum 79.5 / Value 36.4 / Sentiment 39.5
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-17. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$27.00
Analysis reference price unavailable
Analysis 2026-09-17 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$17.00
Analysis reference price unavailable
Analysis 2026-09-17 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-27
Fundamentals (TTM)
As of 2026-10-27
Market Cap
$1.79B
Beta
-
Shares Out
59.56M
P/E (TTM) · Derived
-12.3
P/S (TTM)
-
P/FCF (TTM) · Derived
-13.78
Rev YoY
+66.2%
EPS YoY
-37.2%
Gross Margin
+51.4%
Op Margin
-141.6%
Net Debt
-$149.64M
Current Ratio
4.41
As of 2026-10-27 • Updated nightlySource: Internal modelMethods & Data